Wells Fargo & Company Ars Pharmaceuticals, Inc. Comm Transaction History
Wells Fargo & Company
- $507 Billion
- Q3 2025
A detailed history of Wells Fargo & Company transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Wells Fargo & Company holds 73,842 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,842
Previous 61,106
20.84%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions